Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ News / India/  Serum CEO Adar Poonawalla to get Y category security cover
BackBack

Serum CEO Adar Poonawalla to get Y category security cover

The 'Y' category security comprises 11 personnel, including one or two commandoes and police personnel

Serum Institute of India CEO Adar Poonawalla (MINT_PRINT)Premium
Serum Institute of India CEO Adar Poonawalla (MINT_PRINT)

Serum Institute of India CEO Adar Poonawalla will get 'Y' category security cover by the CRPF, the union home ministry of home affairs notified on Wednesday.

The 'Y' category security comprises 11 personnel, including one or two commandoes and police personnel.

The centre's decision has come after Director, Government and Regulatory Affairs at Pune-based Serum Institute, Prakash Kumar Singh had written to Union Home Minister Amit Shah on April 16 requesting security for Poonawalla.

In this letter, Singh had stated that Poonawalla has been getting threats from various groups regarding the COVID-19 vaccine supplies.

In this letter, Singh also said, "We are working shoulder to shoulder to fight against COVID-19 pandemic with the Government of India under the dynamic leadership of Prime Minister Narendra Modi Ji."

Covishield, one of the two COVID-19 vaccines used in India's COVID-19 vaccination programme, is being manufactured by SII.

Separately, the SII-Pune has announced a cut in price of Covishield it plans to sell to states to 300 per dose from the earlier 400.

Poonawalla announced about this new update on Twitter. He wrote: "As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from 400 to 300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives".

This follows widespread criticism of its pricing policy as the insitute has sold the initial doses of Covishield to the central government at 150 per dose.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 28 Apr 2021, 07:54 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App